The SOLIDITY Trial

The SOLIDITY Trial was a clinical study that evaluated the safety and effectiveness of a medication called sotagliflozin for people with type 1 diabetes. Researchers aimed to see if adding this drug, alongside insulin, could better control blood sugar levels, reduce the risk of complications, and manage side effects. The trial involved careful monitoring of participants to assess outcomes like blood sugar control, weight, and side effects. The findings help determine whether sotagliflozin can be a beneficial addition to diabetes treatment, guiding healthcare decisions and improving patient care.